Sanofi India is currently trading at Rs. 4620.50, up by 120.85 points or 2.69% from its previous closing of Rs. 4499.65 on the BSE.
The scrip opened at Rs. 4646.45 and has touched a high and low of Rs. 4650.00 and Rs. 4600.00 respectively. So far 516 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 4770.00 on 04-Jul-2016 and a 52 week low of Rs. 3676.00 on 24-Jul-2015.
Last one week high and low of the scrip stood at Rs. 4701.00 and Rs. 4450.00 respectively. The current market cap of the company is Rs. 10681.14 crore.
The promoters holding in the company stood at 60.40%, while Institutions and Non-Institutions held 29.40% and 10.20% respectively.
Sanofi India has registered a surge of 32.87% in its net profit at Rs 85.30 crore for the second quarter ended June 30, 2016 as compared to Rs 64.20 crore for the same quarter in the previous year. Total income of the company increased by 11.58% at Rs 624.40 crore for the quarter ended June 30, 2016 as compared Rs 559.60 crore for the corresponding quarter previous year.
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |